BioCentury
ARTICLE | Clinical News

ThermoDox heat-activated liposome: Phase I data

April 6, 2009 7:00 AM UTC

Data from a Phase I trial in 24 patients showed that the median time to treatment failure was 374 days in patients who received radiofrequency ablation (RFA) and >=50 mg/m 2 IV ThermoDox, which is the...